Legion Partners Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6M	Hold	4,461,823	–	–	12.05%	3
2025 Q4	$36.5M	Hold	4,461,823	–	–	21.25%	2
2025 Q3	$32.8M	Buy	4,461,823 +30,000	+0.7%	+$227K	17.77%	4
2025 Q2	$36M	Hold	4,431,823	–	–	21.63%	2
2025 Q1	$31.2M	Hold	4,431,823	–	–	20.71%	2
2024 Q4	$32.9M	Buy	4,431,823 +1,463,414	+49%	+$9.35M	19.21%	3
2024 Q3	$14.6M	Hold	2,968,409	–	–	5.86%	9
2024 Q2	$15.2M	Buy	2,968,409 +18,182	+0.6%	+$108K	5.65%	8
2024 Q1	$15.7M	Buy	2,950,227 +9,887	+0.3%	+$70.7K	3.63%	11
2023 Q4	$18.2M	Hold	2,940,340	–	–	4.74%	9
2023 Q3	$22.2M	Hold	2,940,340	–	–	6.78%	7
2023 Q2	$28.4M	Hold	2,940,340	–	–	8.44%	7
2023 Q1	$11.1M	Hold	2,940,340	–	–	3.27%	11
2022 Q4	$19.1M	Hold	2,940,340	–	–	6.46%	9
2022 Q3	$26.1M	Hold	2,940,340	–	–	9.44%	7
2022 Q2	$29.3M	Hold	2,940,340	–	–	8.87%	5
2022 Q1	$34M	Buy	2,940,340 +12,250	+0.4%	+$136K	8.1%	9
2021 Q4	$32.5M	Hold	2,928,090	–	–	8%	8
2021 Q3	$27M	Hold	2,928,090	–	–	6.49%	9
2021 Q2	$32.9M	Hold	2,928,090	–	–	7.18%	8
2021 Q1	$31M	Buy	2,928,090 +23,750	+0.8%	+$267K	6.73%	7
2020 Q4	$31.5M	Hold	2,904,340	–	–	9.03%	7
2020 Q3	$28.2M	Hold	2,904,340	–	–	7.89%	6
2020 Q2	$23.1M	Buy	2,904,340 +522,847	+22%	+$5.39M	6.7%	5
2020 Q1	$20.7M	Buy	2,381,493 +1,205,388	+102%	+$12.5M	8.91%	5
2019 Q4	$13.3M	Buy	1,176,105 +566,245	+93%	+$6.03M	3.63%	11
2019 Q3	$6.63M	Buy	+609,860	New	+$6.64M	1.68%	11

Other funds holding LFCR